Myeloma Cells Are Highly Sensitive to the Granule Exocytosis Pathway Mediated by WT1-Specific Cytotoxic T Lymphocytes
- 1 November 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (21) , 7402-7412
- https://doi.org/10.1158/1078-0432.ccr-04-0825
Abstract
Purpose: Because WT1 is a universal tumor antigen, we examined the sensitivity of myeloma cells to WT1-specific cytotoxic T lymphocyte (CTL)-mediated cytotoxicity.Experimental Design: WT1 expression in hematologic malignant cells was examined by quantitative reverse transcription-polymerase chain reaction. The cytotoxicity of a WT1-specific CTL clone against hematologic malignant cells, including myeloma cells, was examined by standard chromium-51 release assays. The extent of membrane damage induced by purified perforin was examined. Induction of WT1-specific CTLs from the patients with multiple myeloma (MM) was attempted, and we examined their function against myeloma cells.Results: The expression levels of WT1 mRNA in myeloma and lymphoma cells were significantly lower than that in acute leukemia cells. Although the WT1 expression levels in myeloma and lymphoma cells were almost same, only myeloma cells were lysed efficiently by WT1-specific CTLs in a HLA-restricted manner. The amounts of interferon-γ produced by WT1-specific CTLs in response to stimulation with myeloma cells and with lymphoma cells were almost the same, suggesting that WT1 protein is processed and expressed in the context of HLA class I molecules similarly on both myeloma and lymphoma cells. The extent of membrane damage induced by purified perforin appeared to be significantly higher in myeloma cells than in lymphoma cells. WT1-specific CTLs appeared to be present in patients with MM.Conclusions: The present study has shown that susceptibility of membranes to perforin is an important factor determining the sensitivity of target cells to CTL-mediated cytotoxicity and that WT1 is an ideal target antigen for cellular immunotherapy of MM.Keywords
This publication has 40 references indexed in Scilit:
- Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cellsBlood, 2003
- The Human Cytomegalovirus Protein UL16 Mediates Increased Resistance to Natural Killer Cell Cytotoxicity through Resistance to Cytolytic ProteinsJournal of Virology, 2003
- The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemiaBlood, 2003
- Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myelomaBlood, 2002
- Lymphocyte-Mediated CytotoxicityAnnual Review of Immunology, 2002
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002
- Multiple MyelomaHematology-American Society Hematology Education Program, 2002
- Human Perforin: Rapid Enrichment by Immobilized Metal Affinity Chromatography (IMAC) for Whole Cell Cytotoxicity AssaysBiochemical and Biophysical Research Communications, 1996
- Evidence that a Single Peptide–MHC Complex on a Target Cell Can Elicit a Cytolytic T Cell ResponseImmunity, 1996
- Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytesInternational Immunology, 1996